PCRX 240816 12.50P (PCRX240816P12500) Stock Options, News & Quotes

US OptionsDetailed Quotes

PCRX240816P12500

Watchlist

1.20
+0.79+192.68%

15min DelayClose Aug 9 16:00 ET

1.20High0.35Low

Intraday

5D
Daily

News

Small U.S. Stocks Drop; Pacira BioSciences Falls Furthest
Dow JonesAug 9 17:08 ET
Express News | Pacira BioSciences Shares Resume Trading, Then Again Halt On Circuit Breaker, Shares Down -47.7%
BenzingaAug 9 15:46 ET
Express News | Pacira Biosciences Shares Resume Trading, Last Down 39.6% at $13.50 After Co Says New Jersey Court Found Patent No. 11,033,495 Not Valid
ReutersAug 9 15:42 ET
Express News | Pacira BioSciences Shares Resume Trade
BenzingaAug 9 15:40 ET
Express News | Pacira : We Are Considering Our Legal Options, Which Include Pursuing an Appellate Review at U.S. Court of Appeals for Federal Court as Warranted
ReutersAug 9 15:29 ET
Express News | Pacira Biosciences : U.S. District Court for District of New Jersey Has Found That Company's U.S. Patent No. 11,033,495 ( '495 Patent) Is Not Valid
ReutersAug 9 15:28 ET

Comments

Shroomie

Aug 9 15:03

pew pew.. in and out in 30 seconds

$Pacira BioSciences (PCRX.US)$

Share Your Profit/Loss

Moomoo AI

Mar 14 08:53

Recent insider share sale and lack of insider buying in the past year may concern investors. Despite some alignment between management and smaller shareholders, caution is advised due to recent insider selling activity.

Pacira BioSciences Independent Director Gary Pace Sells 85% Of Holding

Moomoo AI

Feb 4 09:04

Pacira BioSciences' moderate net income growth is seen as a positive despite a low ROE. The growth could be due to good management decisions or a low payout ratio, as it doesn't pay dividends. Analysts predict future earnings momentum.

Should Weakness in Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Moomoo AI

Jan 9 08:22

Multiple insiders selling shares over the past year could be a red flag. However, insider ownership level shows alignment between management and smaller shareholders. Lack of insider purchases in the past year calls for caution.

Pacira BioSciences Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution

Moomoo AI

Nov 24, 2023 12:47

The market seems to tolerate EPS decline but last year's worse-than-average performance may indicate long term investor concerns.

The Three-year Earnings Decline Is Not Helping Pacira BioSciences' (NASDAQ:PCRX Share Price, as Stock Falls Another 4.3% in Past Week